Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
EV/EBIT
16.54 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Teva Pharmaceutical Industries Ltd's enterprise value is $55,353 Mil. Teva Pharmaceutical Industries Ltd's operating income for the trailing twelve months (TTM) ended in Jun. 2014 was $3,258 Mil. Therefore, Teva Pharmaceutical Industries Ltd's EV/EBIT ratio for today is 16.54.

TEVA' s 10-Year EV/EBIT Range
Min: 12   Max: 991
Current: 16.54

12
991

During the past 13 years, the highest EV/EBIT Ratio of Teva Pharmaceutical Industries Ltd was 991.00. The lowest was 12.00. And the median was 21.50.

TEVA's EV/EBITis ranked higher than
86% of the 807 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 33.72 vs. TEVA: 16.54 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Teva Pharmaceutical Industries Ltd's enterprise value for the quarter that ended in Jun. 2014 was $55,228 Mil. Teva Pharmaceutical Industries Ltd's Operating Income for the trailing twelve months (TTM) ended in Jun. 2014 was $3,258 Mil. Teva Pharmaceutical Industries Ltd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2014 was 5.90%.


Definition

Teva Pharmaceutical Industries Ltd's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=55352.800/3258
=16.99

Teva Pharmaceutical Industries Ltd's current Enterprise Value is $55,353 Mil.
Teva Pharmaceutical Industries Ltd's Operating Income for the trailing twelve months (TTM) ended in Jun. 2014 was 801 (Sep. 2013 ) + 560 (Dec. 2013 ) + 972 (Mar. 2014 ) + 925 (Jun. 2014 ) = $3,258 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Teva Pharmaceutical Industries Ltd's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2014 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Jun. 2014 )=Operating Income (TTM)/Enterprise Value (Q: Jun. 2014 )
=3258/55228.33
=5.90 %

Teva Pharmaceutical Industries Ltd's Enterprise Value for the quarter that ended in Jun. 2014 was $55,228 Mil.
Teva Pharmaceutical Industries Ltd's Operating Income for the trailing twelve months (TTM) ended in Jun. 2014 was 801 (Sep. 2013 ) + 560 (Dec. 2013 ) + 972 (Mar. 2014 ) + 925 (Jun. 2014 ) = $3,258 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebit 34.1921.1437.8215.8138.8022.1013.5525.6919.9227.34

Teva Pharmaceutical Industries Ltd Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
ev2ebit 26.7513.1919.4919.9221.0079.6330.6227.3432.0116.95
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide